help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-125-6-2822
Endocrinology Vol. 125, No. 6 2822-2830
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by RUTGERS, MARJA.
Right arrow Articles by VISSER, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RUTGERS, MARJA.
Right arrow Articles by VISSER, T. J.

Enterohepatic Circulation of Triiodothyronine (T3) in Rats: Importance of the Microflora for the Liberation and Reabsorption of T3 from Biliary T3 Conjugates*

MARJA. RUTGERS, FRANK A. HEUSDENS, FRED. BONTHUIS, WOUTER W. DE. HERDER, MAARTEN P. HAZENBERG and THEO J. VISSER

Departments of Internal Medicine III Rotterdam, The Netherlands
Internal Medicine I Rotterdam, The Netherlands
Medical Microbiology, Erasmus University Medical School Rotterdam, The Netherlands

Address all correspondence and requests for reprints to: Theo J. Visser, Ph.D., Department of Internal Medicine III, Erasmus University Medical School, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands

Abstract

In normal rats, T3 glucuronide (T3G) is the major biliary T3 metabolite, but excretion of T3 sulfate (T3S) is greatly increased after inhibition of type I deiodinase, e.g. with 6-propyl-2-thiouracil (PTU). In this study, the fate of the T3 conjugates excreted with bile was studied to assess the significance of a putative enterohepatic circulation of T3 in rats. Conventional (CV) or intestine-decontaminated (ID) rats received iv [125I]T3G or [125I]T3S, the latter usually after pretreatment with PTU (1 mg/100 g BW). Radioactivity in plasma and bile or feces was analyzed by Sephadex LH-20 chromatography and HPLC. Within 1 h, 88% of injected T3G was excreted in bile of CV or ID rats, independent of PTU. About 75% of the injected T3S was excreted within 4 h in PTU-treated rats, in contrast to only 20% in controls. Up to 13 h after iv administration of T3G or T3S (+PTU) to intact ID and CV rats, fecal radioactivity consisted of more than 90% T3 in all CV rats, 95% of T3S in T3S-injected ID rats, and 30% T3 and 67% T3G in T3G-injected ID rats. In overnight-fasted CV rats injected with T3G, total plasma radioactivity rapidly declined until a nadir of 0.10% dose/ml at about 2.5 h, but radioactivity reappeared with a broad maximum of 0.12% dose/ml between 5.5–10 h. In the latter phase, plasma radioactivity consisted of predominantly I" and T3 in a ratio of 2:1. Reabsorption was diminished in fed CV rats and prevented in ID rats. Plasma T3 4–10 h after iv T3G injection to overnight-fasted CV rats was 12, 2, and 3 times higher than that in bile-diverted rats, fed CV rats, and ID rats, respectively, and similar to that 4 h after the injection of T3 itself. Total plasma radioactivity as well as plasma T3 6–13 h after iv administration T3S in PTU-treated rats were significantly increased in CV us. ID rats, e.g. T3 0.016% us. 0.005% dose/ml. These results demonstrate a significant enterohepatic circulation of T3 in rats in which bacterial hydrolysis of T3 conjugates excreted with bile plays an important role.

Footnotes

* Presented in part at the 16th Annual Meeting of the European Thyroid Association, Lausanne, Switzerland, July 5–10, 1987, and was reported previously [Ann Endocrinol 48:134, 1987 (Abstract)]. This work was supported in part by the Foundation for Medical Research MEDIGON(Grant 900–540–191).

Received May 17, 1989.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
J. Laukkarinen, G. Kiudelis, M. Lempinen, S. Raty, H. Pelli, J. Sand, E. Kemppainen, C. Haglund, and I. Nordback
Increased Prevalence of Subclinical Hypothyroidism in Common Bile Duct Stone Patients
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4260 - 4264.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Fujiwara, H. Adachi, T. Nishio, M. Unno, T. Tokui, M. Okabe, T. Onogawa, T. Suzuki, N. Asano, M. Tanemoto, et al.
Identification of Thyroid Hormone Transporters in Humans: Different Molecules Are Involved in a Tissue-Specific Manner
Endocrinology, May 1, 2001; 142(5): 2005 - 2012.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
C. D. Klaassen and A. M. Hood
Effects of Microsomal Enzyme Inducers on Thyroid Follicular Cell Proliferation and Thyroid Hormone Metabolism
Toxicol Pathol, January 1, 2001; 29(1): 34 - 40.
[Abstract] [PDF]


Home page
NEJMHome page
G. N. Burrow, D. A. Fisher, and P. R. Larsen
Maternal and Fetal Thyroid Function
N. Engl. J. Med., October 20, 1994; 331(16): 1072 - 1078.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society